2016 - Positive in-competition test for drostanolone and its metabolite, 2α-methyl-5α-androstan-3α-ol-17-one
March 31, 2016
March 30, 2020
no record
March 12, 2016
USATF Indoor Championship (Track and Field)
athlete, from United States of America, born 1991-09-30, 1 sanction
Notes: Colorado Springs, Colo. (August 24, 2018) USADA announced today that Demi Payne, of Nacogdoches, Texas, an athlete in the sport of track and field, has tested positive for a prohibited substance and accepted a four-year sanction for her violation. Payne, 26, tested positive for drostanolone and its metabolite, 2α-methyl-5α-androstan-3α-ol-17-one, as the result of an in-competition urine sample she provided on March 12, 2016, at the USA Track and Field Indoor Championship. Drostanolone is a non-Specified Substance in the class of anabolic agents and prohibited at all times under the USADA Protocol for Olympic and Paralympic Movement Testing, the United States Olympic Committee National Anti-Doping Policies, and the International Association of Athletics Federations Anti-Doping Rules, all of which have adopted the World Anti-Doping Code and the World Anti-Doping Agency Prohibited List. During USADA’s investigation into the circumstances of Payne’s positive test, an anonymous email was sent to USADA claiming that drinks at the event at which the athlete tested positive were contaminated. Ultimately, after a lengthy and thorough investigation into the email, USADA was able to determine this was not the case. Payne’s four-year period of ineligibility began on March 31, 2016, the date her provisional suspension was imposed. In addition, Payne has been disqualified from competitive results obtained on and subsequent to March 12, 2016, the date her positive sample was collected, including forfeiture of any medals, points and prizes.
March 31, 2016
March 30, 2020
no record
March 12, 2016
USATF Indoor Championship (Track and Field)